Survivors (N = 33, 41.3%) | Died (N = 47, 58.7%) | p value*# | ||
---|---|---|---|---|
Age (years) | Mean ± SD | 38.8 ± 10.7 | 49.2 ± 17.7 | 0.004 |
Gender | N (%) | 0.077 | ||
Male | 24 (72.7) | 25 (53.2) | ||
Female | 9 (27.3) | 22 (46.8) | ||
Hepatomegaly | N (%) | 0.429 | ||
Negative | 16 (48.5) | 27 (57.4) | ||
Positive | 17 (51.5) | 20 (42.6) | ||
Splenomegaly | N (%) | |||
Negative | 12 (36.4) | 17 (36.2) | 1.000 | |
Positive | 21 (63.6) | 30 (63.8) | ||
Lymphadenopathy | N (%) | 0.537 | ||
Negative | 21 (63.6) | 33 (70.2) | ||
Positive | 12 (36.4) | 14 (29.8) | ||
Hemoglobin (g/dl) | Mean ± SD | 6.3 ± 2.5 | 7.1 ± 1.6 | 0.085 |
TLC (× 109/L) | Mean ± SD | 72.4. ± 34.5 | 66.6 ± 46.5 | 0.545 |
Platelets (× 109/L) | Mean ± SD | 24.2 ± 9.5 | 33.5 ± 20.1 | 0.016 |
Blast cells (%) | Mean ± SD | 65.4 ± 17.8 | 76.9 ± 13.6 | 0.002 |
FAB classification | N (%) | 0.082 | ||
M1 | 3 (9.1) | 9 (19.1) | ||
M2 | 16 (48.5) | 28 (59.6) | ||
M4 | 12 (36.4) | 6 (12.8) | ||
M5 | 2 (6.1) | 4 (8.5) | ||
IDH1SNPrs11554137 | N (%) | 0.003 | ||
Normal | 33 (100) | 36 (76.6) | ||
Heterozygous | 0 (0) | 11 (23.4) | ||
IDH2R140Q | N (%) | 0.146 | ||
Normal | 30 (91.3) | 37 (78.7) | ||
Heterozygous | 3 (9.1) | 10 (21.3) |